Matches in Nanopublications for { ?s ?p "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP864138.RAcpG3tZkj40ZuZkM8CYF9y_vGiUZv5Ffmb9wbjUuTlN8130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864138.RAcpG3tZkj40ZuZkM8CYF9y_vGiUZv5Ffmb9wbjUuTlN8130_provenance.
- NP457360.RA2QmVXb-pUitesYIH0WTn2z7cvTSkR7OKilXDJNiWlN0130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457360.RA2QmVXb-pUitesYIH0WTn2z7cvTSkR7OKilXDJNiWlN0130_provenance.
- assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP643285.RABxSrbSMxxdb9y7uwgDSE8r3BhQ0dkb1lzbi-v94qCEg130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643285.RABxSrbSMxxdb9y7uwgDSE8r3BhQ0dkb1lzbi-v94qCEg130_provenance.
- NP643284.RAkrRamgqoSDjPymFBy8Fr_hmYPQ_-a_KruqSx3V_7v0g130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643284.RAkrRamgqoSDjPymFBy8Fr_hmYPQ_-a_KruqSx3V_7v0g130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP402134.RAHOV0dHmkGLEBlsryKqUUAcYp5wJgT4vpw3DFkbfbtGA130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402134.RAHOV0dHmkGLEBlsryKqUUAcYp5wJgT4vpw3DFkbfbtGA130_provenance.